Bicycle Therapeutics Ltd (BCYC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE, UNITED KINGDOM CB22 3AT

Bicycle Therapeutics Ltd. operates as a biotechnology company. The Company offers a platform that combines small molecules and biopharmaceuticals to create drugs. Bicycle Therapeutics serves patients in the United Kingdom and the United States.

View SEC Filings from BCYC instead.

View recent insider trading info

Funds Holding BCYC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCYC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JORDAN VERONICA GH

  • Director
283,673 2020-03-19 3

CROCKETT NIGEL CHIEF BUSINESS OFFICER

  • Officer
0 2020-02-21 5

LEGAULT PIERRE

0 2020-02-12 3

HAU BOSUN

  • Director
0 2020-01-23 3

BINGHAM KATE

  • Director
0 2020-01-02 3

KALOWSKI LEE PRESIDENT AND CFO

  • Officer
0 2020-01-02 3

LEE KEVIN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-01-02 3

KEEN NICHOLAS CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-01-02 3

WINTER GREGORY PAUL

  • Director
0 2020-01-02 3

SKYNNER MICHAEL CHIEF OPERATING OFFICER

  • Officer
0 2020-01-02 3

KENDER RICHARD N

  • Director
0 2020-01-02 3

BOURQUE JANICE

  • Director
0 2020-01-02 3

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 2

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
3,543,067 2019-11-12 2

SVLSF V, LLC

SV LIFE SCIENCES FUND V LP

SV LIFE SCIENCES FUND V (GP), LP

SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.

  • 10% Owner
3,444,833 2019-05-28 2

LEONE PETER BRIAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-05-28 2

VERTEX GLOBAL HEALTHCARE FUND I PTE LTD.

  • 10% Owner
1,621,168 2019-05-28 2

ANSTEY MICHAEL

  • Director
1,751,437 2019-05-28 2

HARLAND DEBORAH

  • Director
1,915,275 2019-05-28 2

NG CAROLYN

  • Director
2,192,597 2019-05-28 3

CAMBRIDGE INNOVATION CAPITAL (JERSEY) LTD

  • 10% Owner
1,751,437 2019-05-28 2

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

TYBOURNE CAPITAL MANAGEMENT LTD

TYBOURNE KESARI LTD

KRISHNAN VISWANATHAN

AQUILA INVESTMENTS IV

  • 10% Owner
1,957,961 2019-05-28 2

AQUILA INVESTMENTS IV

  • 10% Owner
0 2019-05-22 1

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

TYBOURNE CAPITAL MANAGEMENT LTD

TYBOURNE KESARI LTD

KRISHNAN VISWANATHAN

  • 10% Owner
0 2019-05-22 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CROCKETT NIGEL - Officer CHIEF BUSINESS OFFICER

2020-02-21 A 44,757 a 44,757 0.00 direct

Elevate your investments